ensitrelvir: Clinical Trials

2 trials of ensitrelvir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Recruiting 1

Follow ensitrelvir: new trials by email Literature Review of ensitrelvir trials Research Report on ensitrelvir

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Ensitrelvir, Placebo - Long COVID, Post Acute Sequelae of COVID-19
Phase 2Active not recruitingTimothy Henrich402024-04-092026-04-02
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)
Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™) - COVID-19
Phase 2RecruitingUniversity of Oxford38002021-09-302026-02-19

Conditions studied

COVID-19 (1)  ·  Post-Acute COVID-19 Syndrome (1)

Sponsors

Timothy Henrich (1)  ·  University of Oxford (1)

Countries

Brazil (1)  ·  Laos (1)  ·  Nepal (1)  ·  Pakistan (1)  ·  Thailand (1)  ·  United States (1)

Top investigators

Michael Peluso, MD (1)  ·  Timothy Henrich, MD (1)

Results publications

PMID 36803992, PMID 37470445, PMID 37778363, PMID 38225598, PMID 38677300, PMID 39896880, PMID 41082886, PMID 41321979